Impact of communication on first treatment decisions in people with relapsing-remitting multiple sclerosis
Author:
Funder
Multiple Sclerosis Society
National Institute for Health Research
Publisher
Elsevier BV
Subject
General Medicine
Reference39 articles.
1. Diagnosis of multiple sclerosis: 2017 revisions of the Mcdonald criteria;Thompson;Lancet Neurol.,2018
2. National Institute for Health and Care Excellence, Disease-modifying Therapies for Multiple Sclerosis,2020
3. Background information on multiple sclerosis patients stopping ongoing immunomodulatory therapy: a multicenter study in a community-based environment;Bischoff;J. Neurol.,2012
4. Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world;Ziemssen;Ther. Adv. Neurol. Diso.10,2017
5. Long‐term evolution of multiple sclerosis disability in the treatment era;University of California, San Francisco MS Epic Team;Ann. Neurol.,2016
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prevalence of elevated sNFL in a real-world setting: Results on 908 patients with different multiple sclerosis types and treatment conditions;Multiple Sclerosis and Related Disorders;2024-08
2. Decision Making About Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis: Stated Preferences and Real-World Choices;The Patient - Patient-Centered Outcomes Research;2023-04-18
3. Individual Differences in the Patient Experience of Relapsing Multiple Sclerosis (RMS): A Multi-Country Qualitative Exploration of Drivers of Treatment Preferences Among People Living with RMS;The Patient - Patient-Centered Outcomes Research;2023-04-05
4. Communication between persons with multiple sclerosis and their health care providers: A scoping review;Patient Education and Counseling;2022-12
5. Experiences of receiving a diagnosis of multiple sclerosis: a meta-synthesis of qualitative studies;Disability and Rehabilitation;2022-03-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3